Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Colloids Surf B Biointerfaces ; 149: 64-71, 2017 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-27721167

RESUMEN

Changes in cholesterol concentration in the plasma membrane of presynaptic nerve terminals nonspecifically modulate glutamate transport and homeostasis in the central nervous system. Reduction of the cholesterol content in isolated rat brain nerve terminals (synaptosomes) using cholesterol-depleting agents decreases the glutamate uptake and increases the extracellular level of glutamate in nerve terminals. Extraction of cholesterol from the plasma membrane and its further removal from the synaptosomes by external magnetic field can be achieved by means of magnetic nanoparticles with immobilized cholesterol-depleting agent such as O-methyl-ß-cyclodextrin (MCD). A simple approach is developed for preparation of maghemite (γ-Fe2O3) nanoparticles containing chemically bonded MCD. The method is based on preparation of a silanization agent containing MCD. It is synthesized by the reaction of triethoxy(3-isocyanatopropyl)silane with MCD. Base-catalyzed silanization of superparamagnetic γ-Fe2O3 provides a relatively stable colloid product containing 48µmol of MCDg-1. MCD-modified γ-Fe2O3 nanoparticles decrease the initial rate of the uptake and accumulation of l-[14C]glutamate and increase the extracellular l-[14C]glutamate level in the preparation of nerve terminals. The effect of MCD-immobilized nanoparticles is the same as that of MCD solution; moreover, magnetic manipulation of the nanoparticles enables removal of bonded cholesterol.


Asunto(s)
Colesterol/farmacología , Ácido Glutámico/metabolismo , Nanopartículas de Magnetita/química , Terminales Presinápticos/efectos de los fármacos , Sinaptosomas/efectos de los fármacos , beta-Ciclodextrinas/farmacología , Animales , Transporte Biológico/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Radioisótopos de Carbono , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Colesterol/aislamiento & purificación , Colesterol/metabolismo , Compuestos Férricos/química , Cinética , Masculino , Potenciales de la Membrana/efectos de los fármacos , Terminales Presinápticos/metabolismo , Ratas , Ratas Wistar , Silanos/química , Sinaptosomas/metabolismo , beta-Ciclodextrinas/química
2.
Water Res ; 81: 269-78, 2015 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-26074190

RESUMEN

Nine specific compounds identified to migrate from polyethylene (PE) and cross-linked polyethylene (PEX) to drinking water were investigated for their degradation in drinking water. Three sample types were studied: field samples (collected at consumer taps), PEX pipe water extractions, and water samples spiked with target compounds. Four compounds were quantified in field samples at concentrations of 0.15-8.0 µg/L. During PEX pipe water extraction 0.42 ± 0.20 mg NVOC/L was released and five compounds quantified (0.5-6.1 µg/L). The degradation of these compounds was evaluated in PEX-pipe water extractions and spiked samples. 4-ethylphenol was degraded within 22 days. Eight compounds were, however, only partially degradable under abiotic and biotic conditions within the timeframe of the experiments (2-4 weeks). Neither inhibition nor co-metabolism was observed in the presence of acetate or PEX pipe derived NVOC. Furthermore, the degradation in drinking water from four different locations with three different water works was similar. In conclusion, eight out of the nine compounds studied would - if being released from the pipes - reach consumers with only minor concentration decrease during water distribution.


Asunto(s)
Agua Potable/química , Compuestos Orgánicos/análisis , Contaminantes Químicos del Agua/análisis , Dinamarca , Polietileno/química , Factores de Tiempo , Calidad del Agua , Abastecimiento de Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA